Brain perivascular macrophages and the sympathetic response to inflammation in rats after myocardial infarction

Hypertension

Volumn 55, Issue 3, 2010, Pages 652-659

  Yu, Yang ^b   Zhang, Zhi Hua ^b   Wei, Shun Guang ^b   Serrats, Jordi ^b,c   Weiss, Robert M ^b   Felder, Robert B ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

Clodronate liposomes; Cyclooxygenase 2; Cytokines; Heart failure; Inflammation; Myocardial infarction; Perivascular macrophages

Indexed keywords

CLODRONIC ACID; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; LIPOSOME; NORADRENALIN; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CAROTID ARTERY; CEREBROSPINAL FLUID; CONTROLLED STUDY; HEART RATE; IMMUNOREACTIVITY; INFLAMMATION; MACROPHAGE; MALE; NERVE CELL STIMULATION; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RAT; SHAM PROCEDURE; SYMPATHETIC TONE; THALAMUS MIDLINE NUCLEUS;

ANIMALS; BLOOD-BRAIN BARRIER; CLODRONIC ACID; CYCLOOXYGENASE 2; DINOPROSTONE; HEART FAILURE; IMMUNOMODULATION; INFLAMMATION; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-1BETA; LIPOSOMES; MACROPHAGES; MALE; MYOCARDIAL INFARCTION; NOREPINEPHRINE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SYMPATHETIC NERVOUS SYSTEM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77149128988     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.142836     Document Type: Article

References (39)

1. Granger JP. An emerging role for inflammatory cytokines in hypertension. Am J Physiol Heart Circ Physiol. 2006;290:H923-H924.
2. Perin PC, Maule S, Quadri R. Sympathetic nervous system, diabetes, and hypertension. Clin Exp Hypertens. 2001;23:45-55.
3. Yu Y, Kang YM, Zhang ZH, Wei SG, Chu Y, Weiss RM, Felder RB. Increased cyclooxygenase-2 expression in hypothalamic paraventric-ular nucleus in rats with heart failure: role of nuclear factor kappaB. Hypertension. 2007;49:511-518.
4. Yu Y, Zhang ZH, Wei SG, Chu Y, Weiss RM, Heistad DD, Felder RB. Central gene transfer of interleukin-10 reduces hypothalamic inflammation and evidence of heart failure in rats after myocardial infarction. Circ Res. 2007;101:304-312.
5. Straznicky NE, Eikelis N, Lambert EA, Esler MD. Mediators of sympathetic activation in metabolic syndrome obesity. Curr Hypertens Rep. 2008;10:440-447.
6. Felder RB. Mineralocorticoid receptors, inflammation and sympathetic drive in a rat model of systolic heart failure. Exp Physiol. 2010;95:19-25.
7. Felder RB, Yu Y, Zhang ZH, Wei SG. Pharmacological treatment for heart failure: a view from the brain. Clin Pharmacol Ther. 2009;86: 216-220.
8. Schiltz JC, Sawchenko PE. Distinct brain vascular cell types manifest inducible cyclooxygenase expression as a function of the strength and nature of immune insults. J Neurosci. 2002;22:5606-5618.
9. Rivest S. How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology. 2001;26:761-788.
10. Schiltz JC, Sawchenko PE. Signaling the brain in systemic inflammation: the role of perivascular cells. Front Biosci. 2003;8:s1321-s1329.
11. Li YF, Patel KP. Paraventricular nucleus of the hypothalamus and elevated sympathetic activity in heart failure: the altered inhibitory mechanisms. Acta Physiol Scand. 2003;177:17-26.
12. Felder RB, Francis J, Zhang ZH, Wei SG, Weiss RM, Johnson AK. Heart failure and the brain: new perspectives. Am J Physiol Regul Integr Comp Physiol. 2003;284:R259-R276.
13. Van Rooijen N, Sanders A. Liposome mediated depletion of macro-phages: mechanism of action, preparation of liposomes and applications. J Immunol Methods. 1994;174:83-93.
14. Van Rooijen N, Sanders A. Kupffer cell depletion by liposome-delivered drugs: comparative activity of intracellular clodronate, propamidine and ethylenediaminetetraacetic acid. Hepatology. 1996;23:1239-1243.
15. Polfliet MM, Goede PH, van Kesteren-Hendrikx EM, van Rooijen N, Dijkstra CD, van den Berg TK. A method for the selective depletion of perivascular and meningeal macrophages in the central nervous system. J Neuroimmunol. 2001;116:188-195. (Pubitemid 32588631)
16. American Physiological Society. Guiding principles for research involving animals and human beings. Am J Physiol Regul Integr Comp Physiol. 2002;283:R281-R283.
17. Zhang ZH, Wei SG, Francis J, Felder RB. Cardiovascular and renal sympathetic activation by blood-borne TNF-alpha in rat: the role of central prostaglandins. Am J Physiol Regul Integr Comp Physiol. 2003; 284:R916-R927.
18. Kang YM, Zhang ZH, Johnson RF, Yu Y, Beltz T, Johnson AK, Weiss RM, Felder RB. Novel effect of mineralocorticoid receptor antagonism to reduce proinflammatory cytokines and hypothalamic activation in rats with ischemia-induced heart failure. Circ Res. 2006;99:758-766.
19. Francis J, Chu Y, Johnson AK, Weiss RM, Felder RB. Acute myocardial infarction induces hypothalamic cytokine synthesis. Am J Physiol Heart Circ Physiol. 2004;286:H2264-H2271.
20. Pawate S, Shen Q, Fan F, Bhat NR. Redox regulation of glial inflammatory response to lipopolysaccharide and interferongamma. J Neurosci Res. 2004;77:540-551.
21. Block ML, Hong JS. Microglia and inflammation-mediated neurodegen-eration: multiple triggers with a common mechanism. Prog Neurobiol. 2005;76:77-98.
22. Dringen R. Oxidative and antioxidative potential of brain microglial cells. Antioxid Redox Signal. 2005;7:1223-1233.
23. Eder C. Regulation of microglial behavior by ion channel activity. J Neurosci Res. 2005;81:314-321.
24. Breder CD, Dewitt D, Kraig RP. Characterization of inducible cycloox-ygenase in rat brain. J Comp Neurol. 1995;355:296-315.
25. van den Pol AN. The magnocellular and parvocellular paraventricular nucleus of rat: intrinsic organization. J Comp Neurol. 1982;206:317-345.
26. Dunn AJ. Cytokine activation of the HPA axis. Ann N Y Acad Sci. 2000;917:608-617.
27. Kang YM, Ma Y, Elks C, Zheng JP, Yang ZM, Francis J. Cross-talk between cytokines and renin-angiotensin in hypothalamic paraventricular nucleus in heart failure: role of nuclear factor-kappaB. Cardiovasc Res. 2008;79:671-678.
28. Francis J, Zhang ZH, Weiss RM, Felder RB. Neural regulation of the proinflammatory cytokine response to acute myocardial infarction. Am J Physiol Heart Circ Physiol. 2004;287:H791-H797. (Pubitemid 38955314)
29. Hasko G, Pacher P, Deitch EA, Vizi ES. Shaping of monocyte and macrophage function by adenosine receptors. Pharmacol Ther. 2007;113: 264-275.
30. Huang BS, Leenen FH. Blockade of brain mineralocorticoid receptors or Na+ channels prevents sympathetic hyperactivity and improves cardiac function in rats post-MI. Am J Physiol Heart Circ Physiol. 2005;288: H2491-H2497.
31. Huang BS, Ahmad M, Tan J, Leenen FH. Sympathetic hyperactivity and cardiac dysfunction post-MI: different impact of specific CNS versus general AT(1) receptor blockade. J Mol Cell Cardiol. 2007;43:479-486.
32. Kang YM, Zhang ZH, Xue B, Weiss RM, Felder RB. Inhibition of brain proinflammatory cytokine synthesis reduces hypothalamic excitation in rats with ischemia-induced heart failure. Am J Physiol Heart Circ Physiol. 2008;295:H227-H236.
33. DiBona GF. Nervous kidney: interaction between renal sympathetic nerves and the renin-angiotensin system in the control of renal function. Hypertension. 2000;36:1083-1088.
34. Francis J, Wei SG, Weiss RM, Felder RB. Brain angiotensin-converting enzyme activity and autonomic regulation in heart failure. Am J Physiol Heart Circ Physiol. 2004;287:H2138-H2146.
35. Francis J, Weiss RM, Wei SG, Johnson AK, Beltz TG, Zimmerman K, Felder RB. Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure. Am J Physiol Heart Circ Physiol. 2001;281:H2241-H2251.
36. Feldman DS, Carnes CA, Abraham WT, Bristow MR. Mechanisms of disease: beta-adrenergic receptors-alterations in signal transduction and pharmacogenomics in heart failure. Nat Clin Pract Cardiovasc Med. 2005;2:475-483.
37. Francis J, Weiss RM, Wei SG, Johnson AK, Felder RB. Progression of heart failure after myocardial infarction in the rat. Am J Physiol Regul Integr Comp Physiol. 2001;281:R1734-R1745.
38. Sun Y. Myocardial repair/remodelling following infarction: roles of local factors. Cardiovasc Res. 2009;81:482-490.
39. Shi P, Raizada MK, Sumners C. Brain cytokines as neuromodulators in cardiovascular control. Clin Exp Pharmacol Physiol. 2010;37:e52-e57.